Peripheral Neuropathy Trial, Recruiting NCT06896994 Sponsor: Beijing Tiantan Hospital Condition: Peripheral Neuropathy
Back to Peripheral Neuropathy

Peripheral Neuropathy Trial, Recruiting

NCT06896994
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are 18 years of age or older
  • You have had ongoing pain for more than 3 months after a shingles (herpes zoster) skin rash has healed
  • Your average pain level is rated at least 4 out of 10 on a pain scale (where 0 means no pain and 10 means the worst pain imaginable)
  • You have tried pregabalin (a common pain medication) on its own at a full dose, but it either did not work well enough for you or you were unable to tolerate it

Who may not be able to join:

  • You have been diagnosed with obstructive sleep apnoea (a condition where breathing stops and starts during sleep)
  • You are currently receiving any procedure-based pain treatments (such as injections or nerve blocks)
  • You have a history of immune system diseases affecting the whole body, an organ transplant, or any type of cancer
  • You have a history of serious heart, lung, liver, or kidney problems
  • You have a history of schizophrenia, epilepsy, myasthenia gravis, or delirium
  • You are currently taking a type of medication called monoamine oxidase inhibitors (MAOIs)
  • You have a type of glaucoma (raised eye pressure) that has not been treated
  • You have increased pressure inside your skull (confirm with trial site)
  • You have an overactive thyroid or a tumour of the adrenal gland called phaeochromocytoma
  • You have a known or suspected history of drug misuse or addiction
  • You have any known reason you cannot take esketamine, pregabalin, or duloxetine
  • You have significant difficulties with communication
  • You are pregnant, breastfeeding, or currently planning to become pregnant

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 2 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Beijing Tiantan Hospital
Registry
ClinicalTrials.gov
Start date
1 April 2025
Est. completion
1 April 2026

Where this trial is recruiting

🇨🇳 China

Primary endpoints

the mean of daily pain scores

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 2 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov